Revised Schedule M · WHO-GMP · EU-GMP · US FDA — on site and remotely

Selvinium Solutions
Expertise

The forms, the frameworks and the authorities

Experience across the dosage forms and container systems below allows each system, layout and document set to be written for the form in front of it, rather than adapted from a generic template.

  • 12+ dosage forms
  • 15+ agencies faced
  • API to complex injectables
Products & dosage forms supported

A layout that suits dry powder will fail an emulsion

A validation package for an ampoule line has little in common with one written for a tablet block. What follows is where the work has actually been done.

Active pharmaceutical ingredients API & intermediates
Bulk actives and intermediates · reaction, isolation, drying and packing areas · solvent handling, containment and cross-contamination control
Solid oral dosage Oral solids
Uncoated, film-coated and enteric-coated tablets · hard gelatin capsules · dry powder for oral suspension (dry syrup) · powders, granules and sachets
Liquid oral dosage Oral liquids
Syrups · suspensions · solutions and elixirs · oral drops
Small volume parenterals SVP — up to 100 ml
Glass ampoules · liquid-filled glass vials · lyophilised (freeze-dried) vials · dry powder injections for reconstitution · oily and non-aqueous injections
Large volume parenterals LVP — above 100 ml
Infusion solutions in glass and plastic containers · terminally sterilised and aseptically processed presentations
Emulsions & specialised sterile Complex injectables
Fat and lipid emulsions including parenteral nutrition · sterile suspensions · products requiring aseptic processing where terminal sterilisation is not possible
Container & delivery systems Primary packaging
Prefilled syringes · blow-fill-seal (BFS) containers · ampoule, vial, stopper and seal systems · blister, strip, bottle and sachet packing operations
Regulatory frameworks applied

Written against the standard that will judge it

One coherent document set, built so that a single library satisfies the State licensing authority, a WHO or EU inspector and an export customer.

India

Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945 · Revised Schedule M — premises, plant and equipment, pharmaceutical quality system, quality risk management, product quality review and computerised systems · Schedule U records · State FDCA and CDSCO licensing, layout approval and inspection.

United States

21 CFR Part 210 and Part 211 · 21 CFR Part 11 for electronic records and signatures · FDA expectations on process validation lifecycle, investigation quality and data integrity.

European Union

EU GMP Volume 4, Parts I and II · Annex 1 for sterile medicinal products in its revised form · Annex 11 computerised systems · Annex 15 qualification and validation.

World Health Organization

WHO TRS good manufacturing practice guidance · WHO-GMP certification and Certificate of Pharmaceutical Product · documentation expectations applied by WHO-aligned national authorities.

International standards & rest of world

ICH Q7, Q8, Q9 and Q10 · PIC/S principles of good manufacturing practice · requirements applied by African and Latin American health authorities in facility inspection and product registration.

Inspection & audit reach

Agencies faced, from inside the site

Facility inspections faced and supported in quality leadership roles, together with customer, institutional and third-party audits across sterile and non-sterile operations.

  • USFDA United States
  • EU-GMP Europe
  • MHRA United Kingdom
  • TGA Australia
  • WHO Geneva
  • ANVISA Brazil
  • INVIMA Colombia
  • NDA Uganda
  • PPB Kenya
  • TFDA Tanzania
  • EFDA Ethiopia
  • FDA Ghana
  • MOH Congo
  • NSDO Lesotho
  • State FDCA India

Preparation for an inspection is not a document exercise. It is the rehearsal of the people who will answer, against the questions that authority actually asks — and the evidence being on the shelf when it is asked for.

How an assignment runs
Match the expertise to your site

Which forms do you make, and which market is next?

Tell us the dosage forms on the licence, the markets you supply or intend to, and the authority or customer you are preparing for. The answer will state plainly what fits, what does not, and where the effort belongs first.